MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences [Yahoo! Finance]
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
MediWound Ltd. (NASDAQ: MDWD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
What Makes MediWound (MDWD) a Good Fit for 'Trend Investing' [Yahoo! Finance]
MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]